Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
26.56
-0.77 (-2.82%)
Apr 8, 2026, 10:31 AM EDT - Market open

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,3982,439----
Market Cap Growth
48.34%-----
Enterprise Value
2,3292,1960000
Last Close Price
26.5626.24----
PE Ratio
--13.15----
PS Ratio
29.2129.73----
PB Ratio
12.5712.89----
P/TBV Ratio
1.791.76----
EV/Sales Ratio
28.3826.76----
EV/EBITDA Ratio
--11.95----
EV/EBIT Ratio
--11.95----
Debt / Equity Ratio
0.570.573.2416.693.120.84
Debt / EBITDA Ratio
-1.54-1.54-5.66-2.23-2.14-1.13
Debt / FCF Ratio
---12.30-2.33-2.09-1.05
Net Debt / Equity Ratio
-0.37-0.371.5411.620.74-0.53
Net Debt / EBITDA Ratio
0.380.38-1.38-0.87-0.360.69
Net Debt / FCF Ratio
---3.00-0.91-0.350.64
Asset Turnover
0.170.170.380.080.070.01
Inventory Turnover
2.782.782.562.383.291.69
Quick Ratio
1.661.661.151.331.764.98
Current Ratio
1.791.791.261.441.865.22
Return on Equity (ROE)
-154.39%-154.56%-235.32%-386.28%-107.45%-75.18%
Return on Assets (ROA)
-39.07%-39.07%-15.56%-33.66%-31.08%-39.59%
Return on Invested Capital (ROIC)
-121.49%-121.49%-37.32%-84.26%-92.76%-129.70%
Return on Capital Employed (ROCE)
-68.19%-68.19%-25.71%-51.04%-39.80%-48.77%
Earnings Yield
-7.41%-7.60%----
Buyback Yield / Dilution
-17.90%-17.90%-7.00%-7.06%-3.56%-17.93%
Total Shareholder Return
-17.90%-17.90%-7.00%-7.06%-3.56%-17.93%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q